AGO1 and ovarian cancer: To further determine the tumour suppression of PVT1 or AGO1 on ovarian cancer in vivo, BALB/c nude mouse models bearing subcutaneous ovarian xenograft tumours derived from SKOV3 cells stably inhibiting PVT1 or AGO1 were used.